Globally, the RFID sensor market is expected to grow with a CAGR of 9.2% during the forecast period from 2021 to 2029, starting from US$ 12.5 Bn in 2020. The growth of the market is attributed to the increasing adoption of inventory management solutions among the retail and e-commerce sector. Over the past decade, the retail industry is going through a phase of digital disruption.
The global real-time payments market was valued at US$ 6.24 Bn in 2021 and is expected to witness a notable growth, expanding at a CAGR of 14.5% during the forecast period from 2025 to 2033. Real-time payments signifies the most important change to the way funds are moved between bank accounts.
The global xenon light source market is expected to reach US$ 526.5 Mn by 2026, and exhibit sluggish compound annual growth rate of 1.2% during the forecast period from 2018 to 2026. Xenon light sources are characterized by high power and true color projection making in ideal for endoscopy surgeries that require bright light.
The global life science microscopy devices market is expected to grow at a CAGR of 8%. Life science area supports the imaging needs of the scientific community with advanced innovation & technical expertise for the visualization, measurement and analysis of microstructures. It plays a vital role in health care sector, research sector and lab testing.
Optical coherence tomography (OCT) is a non-invasive imaging technology to obtain detailed picture of biological tissue and this high resolution procedure involves near infrared light unlike ultrasound. The wide range application of OCT has evolved with time from ophthalmology to cardiology, dermatology and in research field of life science in order to study the internal structure. The accurate and precise visualization by OCT device increase its demand and so its market.
Companies in the life sciences are advancing in their adoption and use of digital and analytics. Yet, by heeding the lessons of recent years, they may move further and more quickly. Notwithstanding efforts over the past five years, life sciences businesses continue to lag cross-industry leaders in digital maturity by a ratio of two to three in every critical dimension—strategy, culture, organization, and capabilities—with no obvious signs of closing the gap.
Derisking drug discovery, speeding clinical trials, and reimagining engagement with HCPs are the greatest prospects that DnA could assist to realize. As a result, numerous industry leaders are adopting DnA into early-stage drug discovery and clinical development to shorten timeframes and increase the likelihood of success. In addition, market leaders are reimagining their connections with healthcare practitioners and patients in order to offer enhanced and individualized experiences and improve treatment outcomes.
The life sciences are progressively adopting cloud technology to accelerate tech-enabled business changes; by 2021, more than 80 percent of the top 20 global pharma and medtech enterprises will be cloud-based. In addition, businesses are increasingly utilizing the cloud to shift IT infrastructure management and to cover gaps in their software development and analytics skills by purchasing software as a service as opposed to building and maintaining it themselves.
Despite the widespread media interest, longer-term bets such as quantum technologies, Web3, and immersive reality account for just approximately 15% of life sciences technology investments. With a combination of Al and ML, cloud computing, quantum technologies, and bioengineering, for instance, life sciences firms may speed drug development, produce more tailored medicines, and optimize treatment regimens for patients.
Acute Market Reports is a market research and consulting company with a focus on the life sciences industry. Acute Market Reports' futuristic research model benefits our clients by enabling them to make timely, thoughtful business decisions. To deliver cutting-edge strategic research solutions to our international customers, we work with a wide range of industry participants.
